2017/02/02 – Quantum Genomics granted key European patent for QGC011 combination therapy program

Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, today announced the issuance of a key new patent by the European Patent Office.

[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2017/02/QGC_PR_QGC001Combo-Brevet-EU_EN.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]